Showing results (841-850 of 980) with videos related to
Sort By:
Pageof 98
Current Drug Safety|July 4, 2025
Prevalence and Impact of Antibodies Against TNF Alpha Inhibitors in Rheumatoid Arthritis and Spondyloarthritis: Systematic Review and Meta- Analysis with Subgroup AnalysisInes Mahmoud, Selma Bouden, Rim Charfi, et al.Current Drug Safety|May 7, 2025
A Rare Case of Peripheral Edema Induced by Topical Minoxidil: A Case ReportHassan Alkhwildi, Sara Alsaffar, Carina BethlehemCurrent Drug Safety|April 21, 2025
Adverse Drug Reactions of Low and Standard Doses of Risperidone in Schizophrenia OutpatientsTuanthon Boonlue, Praewrawee Karnkla, Sadanan Jansela, et al.Current Drug Safety|March 25, 2025
Clinical Manifestations of Neuropathic Pain and the Deleterious Effects of Chemotherapeutic AgentsMoumita Ghosh, Manodeep Chakraborty, Ananya Bhattacharjee, et al.Current Drug Safety|August 13, 2025
Cisplatin-Based Combinations-Associated Vasculopathy - A Disproportionality Analysis of Real-World Pharmacovigilance DataKrutarth K Pandya, Chitsimran Mann, Wei Fang, et al.Current Drug Safety|March 27, 2025
Pharmacovigilance in Geriatrics: Exploration of Etio-Clinical Profile and Severity of Adverse Drug Reactions at a Tertiary Hospital in South IndiaJerin James, Gowtham B, Kala P, et al.Current Drug Safety|May 10, 2013
The future of risk communication and the role of the pharmaceutical industrySweta Chakraborty, Frederic BouderCurrent Drug Safety|May 10, 2013
Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical educationCarl N Kraus, Alan T Baldwin, R G McAllisterCurrent Drug Safety|May 10, 2013
The practicing clinician and regulatory safety concernsR G McAllister, Timothy Franson, Carl N KrausCurrent Drug Safety|May 10, 2013
Defining the pharmaceutical system to support proactive drug safetyVicki R Lewis, Angelica Hernandez, Margaret MeadorsPageof 98